Zhejiang CONBA Pharmaceutical Co.,Ltd. (600572.SS)
CNY 4.39
(-1.35%)
CNY 4.39
(-1.35%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -1.53 Billion CNY | -20.66% |
| 2022 | -1.27 Billion CNY | -27.07% |
| 2021 | -1 Billion CNY | -227.31% |
| 2020 | 785.82 Million CNY | -20.81% |
| 2019 | 992.28 Million CNY | 3.06% |
| 2018 | 962.78 Million CNY | 270.69% |
| 2017 | -564.04 Million CNY | -817.06% |
| 2016 | 78.66 Million CNY | -88.11% |
| 2015 | 661.5 Million CNY | -39.25% |
| 2014 | 1.08 Billion CNY | 291.76% |
| 2013 | 277.95 Million CNY | 224.85% |
| 2012 | -222.63 Million CNY | -303.54% |
| 2011 | 109.38 Million CNY | 136.58% |
| 2010 | -299.04 Million CNY | -327.57% |
| 2009 | 131.4 Million CNY | 98.99% |
| 2008 | 66.03 Million CNY | -16.16% |
| 2007 | 78.76 Million CNY | -50.26% |
| 2006 | 158.34 Million CNY | 369.56% |
| 2005 | 33.72 Million CNY | 150.08% |
| 2004 | -67.33 Million CNY | -175.4% |
| 2003 | 89.29 Million CNY | 9.21% |
| 2002 | 81.76 Million CNY | 176.48% |
| 2001 | 29.57 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -469.26 Million CNY | 13.35% |
| 2024 Q2 | -536.33 Million CNY | 59.04% |
| 2024 Q1 | -1.3 Billion CNY | 14.64% |
| 2023 Q1 | -787.47 Million CNY | 38.05% |
| 2023 Q2 | -1.2 Billion CNY | -52.95% |
| 2023 Q3 | -1.64 Billion CNY | -36.37% |
| 2023 Q4 | -1.53 Billion CNY | 6.61% |
| 2023 FY | -1.53 Billion CNY | -20.66% |
| 2022 Q2 | -969.19 Million CNY | 19.2% |
| 2022 Q4 | -1.27 Billion CNY | -90.39% |
| 2022 FY | -1.27 Billion CNY | -27.07% |
| 2022 Q1 | -1.19 Billion CNY | -19.9% |
| 2022 Q3 | -667.68 Million CNY | 31.11% |
| 2021 Q3 | 558.69 Million CNY | -16.88% |
| 2021 Q2 | 672.13 Million CNY | -12.13% |
| 2021 Q1 | 764.89 Million CNY | -2.66% |
| 2021 FY | -1 Billion CNY | -227.31% |
| 2021 Q4 | -1 Billion CNY | -279.07% |
| 2020 Q4 | 785.82 Million CNY | 15.17% |
| 2020 Q1 | 758.36 Million CNY | -23.57% |
| 2020 Q3 | 682.29 Million CNY | -18.48% |
| 2020 Q2 | 837 Million CNY | 10.37% |
| 2020 FY | 785.82 Million CNY | -20.81% |
| 2019 Q4 | 992.28 Million CNY | -11.24% |
| 2019 Q2 | 1.31 Billion CNY | 30.23% |
| 2019 Q1 | 1 Billion CNY | 4.61% |
| 2019 FY | 992.28 Million CNY | 3.06% |
| 2019 Q3 | 1.11 Billion CNY | -14.77% |
| 2018 Q3 | 833.41 Million CNY | 68.32% |
| 2018 Q4 | 962.78 Million CNY | 15.52% |
| 2018 Q2 | 495.14 Million CNY | 184.49% |
| 2018 Q1 | -586.05 Million CNY | -3.9% |
| 2018 FY | 962.78 Million CNY | 270.69% |
| 2017 Q1 | 54.73 Million CNY | -30.42% |
| 2017 FY | -564.04 Million CNY | -817.06% |
| 2017 Q2 | 600.68 Million CNY | 997.5% |
| 2017 Q3 | 614.78 Million CNY | 2.35% |
| 2017 Q4 | -564.04 Million CNY | -191.75% |
| 2016 FY | 78.66 Million CNY | -88.11% |
| 2016 Q2 | 585.65 Million CNY | 10.82% |
| 2016 Q1 | 528.49 Million CNY | -20.11% |
| 2016 Q3 | 641.34 Million CNY | 9.51% |
| 2016 Q4 | 78.66 Million CNY | -87.74% |
| 2015 Q2 | 171.79 Million CNY | -83.16% |
| 2015 Q4 | 661.5 Million CNY | 1.53% |
| 2015 Q3 | 651.52 Million CNY | 279.25% |
| 2015 FY | 661.5 Million CNY | -39.25% |
| 2015 Q1 | 1.02 Billion CNY | -6.32% |
| 2014 FY | 1.08 Billion CNY | 291.76% |
| 2014 Q1 | 148.22 Million CNY | -46.67% |
| 2014 Q2 | 578.59 Million CNY | 290.35% |
| 2014 Q3 | 997.59 Million CNY | 72.42% |
| 2014 Q4 | 1.08 Billion CNY | 9.15% |
| 2013 Q4 | 277.95 Million CNY | -21.2% |
| 2013 FY | 277.95 Million CNY | 224.85% |
| 2013 Q3 | 352.72 Million CNY | 19.95% |
| 2013 Q2 | 294.05 Million CNY | 159.02% |
| 2013 Q1 | 113.52 Million CNY | 150.99% |
| 2012 Q4 | -222.63 Million CNY | -144.59% |
| 2012 Q3 | 499.27 Million CNY | 100.49% |
| 2012 Q2 | 249.03 Million CNY | 103.38% |
| 2012 FY | -222.63 Million CNY | -303.54% |
| 2012 Q1 | 122.44 Million CNY | 11.94% |
| 2011 Q4 | 109.38 Million CNY | 293.43% |
| 2011 Q1 | -306 Million CNY | -2.33% |
| 2011 Q2 | -289.59 Million CNY | 5.36% |
| 2011 Q3 | -56.54 Million CNY | 80.47% |
| 2011 FY | 109.38 Million CNY | 136.58% |
| 2010 Q2 | 87.13 Million CNY | -20.77% |
| 2010 FY | -299.04 Million CNY | -327.57% |
| 2010 Q3 | 115.8 Million CNY | 32.89% |
| 2010 Q1 | 109.98 Million CNY | -16.31% |
| 2010 Q4 | -299.04 Million CNY | -358.24% |
| 2009 Q1 | 93.48 Million CNY | 41.56% |
| 2009 FY | 131.4 Million CNY | 98.99% |
| 2009 Q4 | 131.4 Million CNY | -6.18% |
| 2009 Q3 | 140.06 Million CNY | 196.37% |
| 2009 Q2 | 47.25 Million CNY | -49.45% |
| 2008 Q4 | 66.03 Million CNY | -48.26% |
| 2008 FY | 66.03 Million CNY | -16.16% |
| 2008 Q3 | 127.63 Million CNY | 7.42% |
| 2008 Q2 | 118.81 Million CNY | -11.44% |
| 2008 Q1 | 134.16 Million CNY | 70.34% |
| 2007 Q2 | 206.99 Million CNY | -6.43% |
| 2007 Q3 | 242.2 Million CNY | 17.01% |
| 2007 FY | 78.76 Million CNY | -50.26% |
| 2007 Q4 | 78.76 Million CNY | -67.48% |
| 2007 Q1 | 221.23 Million CNY | 39.71% |
| 2006 Q1 | 104.98 Million CNY | 211.33% |
| 2006 Q3 | 218.2 Million CNY | 100.38% |
| 2006 Q4 | 158.34 Million CNY | -27.43% |
| 2006 FY | 158.34 Million CNY | 369.56% |
| 2006 Q2 | 108.89 Million CNY | 3.72% |
| 2005 FY | 33.72 Million CNY | 150.08% |
| 2005 Q4 | 33.72 Million CNY | 214.44% |
| 2005 Q3 | 10.72 Million CNY | 206.24% |
| 2005 Q1 | -54.85 Million CNY | 18.53% |
| 2005 Q2 | -10.09 Million CNY | 81.6% |
| 2004 Q2 | -53.95 Million CNY | -146.59% |
| 2004 Q1 | 115.8 Million CNY | 29.69% |
| 2004 FY | -67.33 Million CNY | -175.4% |
| 2004 Q4 | -67.33 Million CNY | -12.13% |
| 2004 Q3 | -60.04 Million CNY | -11.3% |
| 2003 Q4 | 89.29 Million CNY | 0.0% |
| 2003 FY | 89.29 Million CNY | 9.21% |
| 2002 FY | 81.76 Million CNY | 176.48% |
| 2001 FY | 29.57 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | -20.67 Billion CNY | 92.579% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 248.15 Million CNY | 718.137% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | -309.42 Million CNY | -395.728% |
| Aurora Optoelectronics Co.,Ltd. | -251.17 Million CNY | -510.706% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 16.8 Million CNY | 9228.355% |
| NanJing Pharmaceutical Company Limited | 9.24 Billion CNY | 116.592% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 32.59 Million CNY | 4805.78% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | -954.2 Million CNY | -60.753% |